Cover Image
Market Research Report
Product code 
1041734

Global and Japan Biomarker Testing Market Size, Status and Forecast 2021-2027

Published: | QYResearch | 89 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global and Japan Biomarker Testing Market Size, Status and Forecast 2021-2027
Published: November 30, 2021
QYResearch
Content info: 89 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Market Analysis and Insights: Global Biomarker Testing Market

The global Biomarker Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biomarker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biomarker Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biomarker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biomarker Testing market.

Global Biomarker Testing Scope and Market Size

Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

  • Sepsis Biomarkers
  • Antibiotic Resistance Biomarkers
  • Traumatic Brain Injury (TBI) Testing Biomarkers
  • Stroke Testing Biomarkers
  • Antibiotic Stewardship Biomarkers
  • Others

Segment by Application

  • Hospital
  • Diagnostic Center
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

By Company

  • Agilent Technologies
  • Roche

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Sepsis Biomarkers
    • 1.2.3 Antibiotic Resistance Biomarkers
    • 1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
    • 1.2.5 Stroke Testing Biomarkers
    • 1.2.6 Antibiotic Stewardship Biomarkers
    • 1.2.7 Others
  • 1.3 Market by Application
    • 1.3.1 Global Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Diagnostic Center
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biomarker Testing Market Perspective (2016-2027)
  • 2.2 Biomarker Testing Growth Trends by Regions
    • 2.2.1 Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Biomarker Testing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Biomarker Testing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Biomarker Testing Industry Dynamic
    • 2.3.1 Biomarker Testing Market Trends
    • 2.3.2 Biomarker Testing Market Drivers
    • 2.3.3 Biomarker Testing Market Challenges
    • 2.3.4 Biomarker Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biomarker Testing Players by Revenue
    • 3.1.1 Global Top Biomarker Testing Players by Revenue (2016-2021)
    • 3.1.2 Global Biomarker Testing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biomarker Testing Revenue
  • 3.4 Global Biomarker Testing Market Concentration Ratio
    • 3.4.1 Global Biomarker Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biomarker Testing Revenue in 2020
  • 3.5 Biomarker Testing Key Players Head office and Area Served
  • 3.6 Key Players Biomarker Testing Product Solution and Service
  • 3.7 Date of Enter into Biomarker Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biomarker Testing Breakdown Data by Type

  • 4.1 Global Biomarker Testing Historic Market Size by Type (2016-2021)
  • 4.2 Global Biomarker Testing Forecasted Market Size by Type (2022-2027)

5 Biomarker Testing Breakdown Data by Application

  • 5.1 Global Biomarker Testing Historic Market Size by Application (2016-2021)
  • 5.2 Global Biomarker Testing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Biomarker Testing Market Size (2016-2027)
  • 6.2 North America Biomarker Testing Market Size by Type
    • 6.2.1 North America Biomarker Testing Market Size by Type (2016-2021)
    • 6.2.2 North America Biomarker Testing Market Size by Type (2022-2027)
    • 6.2.3 North America Biomarker Testing Market Size by Type (2016-2027)
  • 6.3 North America Biomarker Testing Market Size by Application
    • 6.3.1 North America Biomarker Testing Market Size by Application (2016-2021)
    • 6.3.2 North America Biomarker Testing Market Size by Application (2022-2027)
    • 6.3.3 North America Biomarker Testing Market Size by Application (2016-2027)
  • 6.4 North America Biomarker Testing Market Size by Country
    • 6.4.1 North America Biomarker Testing Market Size by Country (2016-2021)
    • 6.4.2 North America Biomarker Testing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Biomarker Testing Market Size (2016-2027)
  • 7.2 Europe Biomarker Testing Market Size by Type
    • 7.2.1 Europe Biomarker Testing Market Size by Type (2016-2021)
    • 7.2.2 Europe Biomarker Testing Market Size by Type (2022-2027)
    • 7.2.3 Europe Biomarker Testing Market Size by Type (2016-2027)
  • 7.3 Europe Biomarker Testing Market Size by Application
    • 7.3.1 Europe Biomarker Testing Market Size by Application (2016-2021)
    • 7.3.2 Europe Biomarker Testing Market Size by Application (2022-2027)
    • 7.3.3 Europe Biomarker Testing Market Size by Application (2016-2027)
  • 7.4 Europe Biomarker Testing Market Size by Country
    • 7.4.1 Europe Biomarker Testing Market Size by Country (2016-2021)
    • 7.4.2 Europe Biomarker Testing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Biomarker Testing Market Size (2016-2027)
  • 8.2 Asia-Pacific Biomarker Testing Market Size by Type
    • 8.2.1 Asia-Pacific Biomarker Testing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Biomarker Testing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Biomarker Testing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Biomarker Testing Market Size by Application
    • 8.3.1 Asia-Pacific Biomarker Testing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Biomarker Testing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Biomarker Testing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Biomarker Testing Market Size by Region
    • 8.4.1 Asia-Pacific Biomarker Testing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Biomarker Testing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Biomarker Testing Market Size (2016-2027)
  • 9.2 Latin America Biomarker Testing Market Size by Type
    • 9.2.1 Latin America Biomarker Testing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Biomarker Testing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Biomarker Testing Market Size by Type (2016-2027)
  • 9.3 Latin America Biomarker Testing Market Size by Application
    • 9.3.1 Latin America Biomarker Testing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Biomarker Testing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Biomarker Testing Market Size by Application (2016-2027)
  • 9.4 Latin America Biomarker Testing Market Size by Country
    • 9.4.1 Latin America Biomarker Testing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Biomarker Testing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Biomarker Testing Market Size (2016-2027)
  • 10.2 Middle East & Africa Biomarker Testing Market Size by Type
    • 10.2.1 Middle East & Africa Biomarker Testing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Biomarker Testing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Biomarker Testing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Biomarker Testing Market Size by Application
    • 10.3.1 Middle East & Africa Biomarker Testing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Biomarker Testing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Biomarker Testing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Biomarker Testing Market Size by Country
    • 10.4.1 Middle East & Africa Biomarker Testing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Biomarker Testing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Agilent Technologies
    • 11.1.1 Agilent Technologies Company Details
    • 11.1.2 Agilent Technologies Business Overview
    • 11.1.3 Agilent Technologies Biomarker Testing Introduction
    • 11.1.4 Agilent Technologies Revenue in Biomarker Testing Business (2016-2021)
    • 11.1.5 Agilent Technologies Recent Development
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Biomarker Testing Introduction
    • 11.2.4 Roche Revenue in Biomarker Testing Business (2016-2021)
    • 11.2.5 Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

List of Tables

  • Table 1. Global Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
  • Table 2. Key Players of Sepsis Biomarkers
  • Table 3. Key Players of Antibiotic Resistance Biomarkers
  • Table 4. Key Players of Traumatic Brain Injury (TBI) Testing Biomarkers
  • Table 5. Key Players of Stroke Testing Biomarkers
  • Table 6. Key Players of Antibiotic Stewardship Biomarkers
  • Table 7. Key Players of Others
  • Table 8. Global Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
  • Table 9. Global Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
  • Table 10. Global Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million)
  • Table 11. Global Biomarker Testing Market Share by Regions (2016-2021)
  • Table 12. Global Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
  • Table 13. Global Biomarker Testing Market Share by Regions (2022-2027)
  • Table 14. Biomarker Testing Market Trends
  • Table 15. Biomarker Testing Market Drivers
  • Table 16. Biomarker Testing Market Challenges
  • Table 17. Biomarker Testing Market Restraints
  • Table 18. Global Biomarker Testing Revenue by Players (2016-2021) & (US$ Million)
  • Table 19. Global Biomarker Testing Market Share by Players (2016-2021)
  • Table 20. Global Top Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Testing as of 2020)
  • Table 21. Ranking of Global Top Biomarker Testing Companies by Revenue (US$ Million) in 2020
  • Table 22. Global 5 Largest Players Market Share by Biomarker Testing Revenue (CR5 and HHI) & (2016-2021)
  • Table 23. Key Players Headquarters and Area Served
  • Table 24. Key Players Biomarker Testing Product Solution and Service
  • Table 25. Date of Enter into Biomarker Testing Market
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
  • Table 28. Global Biomarker Testing Revenue Market Share by Type (2016-2021)
  • Table 29. Global Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
  • Table 30. Global Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
  • Table 31. Global Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million)
  • Table 32. Global Biomarker Testing Revenue Market Share by Application (2016-2021)
  • Table 33. Global Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
  • Table 34. Global Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
  • Table 35. North America Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
  • Table 36. North America Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
  • Table 37. North America Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
  • Table 38. North America Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
  • Table 39. North America Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
  • Table 40. North America Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
  • Table 41. Europe Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
  • Table 42. Europe Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
  • Table 43. Europe Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
  • Table 44. Europe Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
  • Table 45. Europe Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
  • Table 46. Europe Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
  • Table 47. Asia-Pacific Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
  • Table 48. Asia-Pacific Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
  • Table 49. Asia-Pacific Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
  • Table 50. Asia-Pacific Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
  • Table 51. Asia-Pacific Biomarker Testing Market Size by Region (2016-2021) & (US$ Million)
  • Table 52. Asia-Pacific Biomarker Testing Market Size by Region (2022-2027) & (US$ Million)
  • Table 53. Latin America Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
  • Table 54. Latin America Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
  • Table 55. Latin America Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
  • Table 56. Latin America Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
  • Table 57. Latin America Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
  • Table 58. Latin America Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
  • Table 59. Middle East & Africa Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
  • Table 60. Middle East & Africa Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
  • Table 61. Middle East & Africa Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
  • Table 62. Middle East & Africa Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
  • Table 63. Middle East & Africa Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
  • Table 64. Middle East & Africa Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
  • Table 65. Agilent Technologies Company Details
  • Table 66. Agilent Technologies Business Overview
  • Table 67. Agilent Technologies Biomarker Testing Product
  • Table 68. Agilent Technologies Revenue in Biomarker Testing Business (2016-2021) & (US$ Million)
  • Table 69. Agilent Technologies Recent Development
  • Table 70. Roche Company Details
  • Table 71. Roche Business Overview
  • Table 72. Roche Biomarker Testing Product
  • Table 73. Roche Revenue in Biomarker Testing Business (2016-2021) & (US$ Million)
  • Table 74. Roche Recent Development
  • Table 75. Research Programs/Design for This Report
  • Table 76. Key Data Information from Secondary Sources
  • Table 77. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Biomarker Testing Market Share by Type: 2020 VS 2027
  • Figure 2. Sepsis Biomarkers Features
  • Figure 3. Antibiotic Resistance Biomarkers Features
  • Figure 4. Traumatic Brain Injury (TBI) Testing Biomarkers Features
  • Figure 5. Stroke Testing Biomarkers Features
  • Figure 6. Antibiotic Stewardship Biomarkers Features
  • Figure 7. Others Features
  • Figure 8. Global Biomarker Testing Market Share by Application: 2020 VS 2027
  • Figure 9. Hospital Case Studies
  • Figure 10. Diagnostic Center Case Studies
  • Figure 11. Others Case Studies
  • Figure 12. Biomarker Testing Report Years Considered
  • Figure 13. Global Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
  • Figure 14. Global Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
  • Figure 15. Global Biomarker Testing Market Share by Regions: 2020 VS 2027
  • Figure 16. Global Biomarker Testing Market Share by Regions (2022-2027)
  • Figure 17. Global Biomarker Testing Market Share by Players in 2020
  • Figure 18. Global Top Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Testing as of 2020
  • Figure 19. The Top 10 and 5 Players Market Share by Biomarker Testing Revenue in 2020
  • Figure 20. Global Biomarker Testing Revenue Market Share by Type (2016-2021)
  • Figure 21. Global Biomarker Testing Revenue Market Share by Type (2022-2027)
  • Figure 22. North America Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 23. North America Biomarker Testing Market Share by Type (2016-2027)
  • Figure 24. North America Biomarker Testing Market Share by Application (2016-2027)
  • Figure 25. North America Biomarker Testing Market Share by Country (2016-2027)
  • Figure 26. United States Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 27. Canada Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 28. Europe Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 29. Europe Biomarker Testing Market Share by Type (2016-2027)
  • Figure 30. Europe Biomarker Testing Market Share by Application (2016-2027)
  • Figure 31. Europe Biomarker Testing Market Share by Country (2016-2027)
  • Figure 32. Germany Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 33. France Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 34. U.K. Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 35. Italy Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 36. Russia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 37. Nordic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 38. Asia-Pacific Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 39. Asia-Pacific Biomarker Testing Market Share by Type (2016-2027)
  • Figure 40. Asia-Pacific Biomarker Testing Market Share by Application (2016-2027)
  • Figure 41. Asia-Pacific Biomarker Testing Market Share by Region (2016-2027)
  • Figure 42. China Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 43. Japan Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 44. South Korea Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 45. Southeast Asia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 46. India Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 47. Australia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 48. Latin America Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 49. Latin America Biomarker Testing Market Share by Type (2016-2027)
  • Figure 50. Latin America Biomarker Testing Market Share by Application (2016-2027)
  • Figure 51. Latin America Biomarker Testing Market Share by Country (2016-2027)
  • Figure 52. Mexico Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 53. Brazil Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 54. Middle East & Africa Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 55. Middle East & Africa Biomarker Testing Market Share by Type (2016-2027)
  • Figure 56. Middle East & Africa Biomarker Testing Market Share by Application (2016-2027)
  • Figure 57. Middle East & Africa Biomarker Testing Market Share by Country (2016-2027)
  • Figure 58. Turkey Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 59. Saudi Arabia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 60. UAE Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 61. Agilent Technologies Revenue Growth Rate in Biomarker Testing Business (2016-2021)
  • Figure 62. Roche Revenue Growth Rate in Biomarker Testing Business (2016-2021)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed